The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of trifluridine/tipiracil (TAS-102) effectiveness in patients with refractory metastatic colorectal cancer (mCRC): Real-life data from the Czech Republic.
 
Peter Grell
Travel, Accommodations, Expenses - Bayer; SERVIER
 
Josef Dvorak
No Relationships to Disclose
 
Michal Vocka
No Relationships to Disclose
 
Stanislav John
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Novartis; Roche; SERVIER
 
Helena Tuskova
No Relationships to Disclose
 
Tomas Buchler
Honoraria - Amgen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer; Roche
Research Funding - MSD; Roche
Travel, Accommodations, Expenses - Janssen
 
Simona Borilova
No Relationships to Disclose
 
Iveta Selingerova
No Relationships to Disclose
 
Rostislav Vyzula
No Relationships to Disclose
 
Lubos B. Petruzelka
No Relationships to Disclose
 
Igor Kiss
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Roche; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; SERVIER
 
Radka Obermannova
Travel, Accommodations, Expenses - Novartis; Roche; SERVIER